Top Markets
#1 B3 (Base) B3 (Base) +14.17%
#2 Janction Janction +12.47%
#3 DMT-NAT DMT-NAT +11.90%
#4 Fake World Assets Fake World Assets +11.22%
#5 TENDIES TENDIES +6.21%
#6 Status Status +4.85%
#7 GoPlus Security GoPlus Security +4.76%
#8 龙虾 (Lobster) 龙虾 (Lobster) +4.30%
#9 Provenance Blockchain Provenance Blockchain +3.88%
#10 Everything Everything +3.72%
Coin of the day
B3 (Base) B3 (Base)
Settings
Language
ENGLISH
Currency
USD
Theme
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Rank in Stocks #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Share Price
$0.617
Last synced: 2024-10-14
Market Cap
$6.13M
Change (1 day)
0.49%
Change (1 year)
0.00%
Country
US
Trade Kineta, Inc. (KA)

Category

Healthcare
Earnings for Kineta, Inc. (KA)
Earnings in Mar 2025 TTM: $-7.68M
According to Kineta, Inc. latest financial reports the company's current earnings are $-7.68M. In 2023 the company made an earning of $-14.08M, an increase over its 2022 earnings that were of $-63.45M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Kineta, Inc. from 2015 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-7.68M -55.17%
2024 $-17.13M 21.71%
2023 $-14.08M -77.82%
2022 $-63.45M 436.96%
2021 $-11.82M 66.16%
2020 $-7.11M -87.97%
2019 $-59.13M -4.38%
2018 $-61.83M 4.04%
2017 $-59.43M 59.63%
2016 $-37.23M 48.69%
2015 $-25.04M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -68,774.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -25,495.78%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -39,231.85%
BE